论文部分内容阅读
Pancreatic adenocarcinoma remains one of the deadliest malignancies affecting the older population.We are experiencing a paradigm shift in the treatment of pancreatic cancer in the era of coronavirus disease 2019(COVID-19)pandemic.Utilizing neoadjuvant tr